{"id":21530,"date":"2023-12-11T10:20:13","date_gmt":"2023-12-11T09:20:13","guid":{"rendered":"https:\/\/ggba.swiss\/?p=21530"},"modified":"2023-12-11T10:20:14","modified_gmt":"2023-12-11T09:20:14","slug":"diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/","title":{"rendered":"Diatheris to spearhead a new era in Type 1 diabetes management"},"content":{"rendered":"\n<p>Founded on the groundbreaking research of Giorgio Ramadori from UNIGE&#8217;s <a href=\"https:\/\/www.unige.ch\/medecine\/phym\/home\">Department of Cell Physiology and Metabolism<\/a> and the <a href=\"https:\/\/www.unige.ch\/medecine\/diabetescentre\/en\">Faculty Diabetes Centre<\/a>, Diatheris stands at the forefront of a major medical breakthrough. Ramadori&#8217;s research, spanning over a decade, culminates in the development of a novel treatment strategy involving the protein S100A9. This protein has shown promise in prolonging life and improving health markers in insulin-deficient mice, setting the stage for transformative human applications.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.diatheris.com\/\">Diatheris<\/a>&#8216; approach focuses on a subcutaneous injection of a recombinant form of S100A9. This treatment aims to offer a safer, more effective, and less restrictive alternative to traditional insulin therapies. The potential benefits are far-reaching, promising to reduce insulin dependency while mitigating risks associated with hypoglycemia and diabetic ketoacidosis \u2013 common and serious challenges in current diabetes treatments.<\/p>\n\n\n\n<p>The grant from the <a href=\"https:\/\/helmsleytrust.org\/\">Helmsley Charitable Trust<\/a> will enable Diatheris to complete of essential pre-clinical studies and paving the way for clinical trial applications by 2025. This milestone marks a significant advancement in the start-up&#8217;s journey, highlighting a shared commitment to enhancing medical knowledge and improving the lives of those affected by type 1 diabetes.<\/p>\n\n\n\n<p>Beyond the Helmsley Charitable Trust, Diatheris has garnered support from various sources, including an <a href=\"https:\/\/www.innosuisse.ch\/inno\/en\/home.html\">Innosuisse<\/a> grant, funding from <a href=\"https:\/\/www.venturekick.ch\/\">Venture Kick<\/a>, and support from <a href=\"https:\/\/www.fongit.ch\/\">FONGIT<\/a>. These endorsements not only underscore the start-up&#8217;s potential but also reflect the broader commitment to fostering innovative medical solutions within the Swiss healthcare ecosystem.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diatheris, a start-up emerging from the University of Geneva (UNIGE), has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.<\/p>\n","protected":false},"author":6,"featured_media":21531,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[949,894,890,902,886],"class_list":["post-21530","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-education-en","tag-financing","tag-healthcare","tag-personalized-medicine","tag-rd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diatheris to spearhead a new era in Type 1 diabetes management<\/title>\n<meta name=\"description\" content=\"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diatheris to spearhead a new era in Type 1 diabetes management\" \/>\n<meta property=\"og:description\" content=\"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-11T09:20:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-11T09:20:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Diatheris to spearhead a new era in Type 1 diabetes management\",\"datePublished\":\"2023-12-11T09:20:13+00:00\",\"dateModified\":\"2023-12-11T09:20:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\"},\"wordCount\":246,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png\",\"keywords\":[\"Education\",\"Financing\",\"Healthcare\",\"Personalized Medicine\",\"R&amp;D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\",\"url\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\",\"name\":\"Diatheris to spearhead a new era in Type 1 diabetes management\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png\",\"datePublished\":\"2023-12-11T09:20:13+00:00\",\"dateModified\":\"2023-12-11T09:20:14+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"This significant funding propels the Diatheris\u2019 efforts to revolutionize type 1 diabetes management through innovative treatment methodologies (from left to right: Pr. Roberto Coppari and Dr Giorgio Rimadori). | \u00a9 Diatheris\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diatheris to spearhead a new era in Type 1 diabetes management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diatheris to spearhead a new era in Type 1 diabetes management","description":"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/","og_locale":"en_US","og_type":"article","og_title":"Diatheris to spearhead a new era in Type 1 diabetes management","og_description":"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.","og_url":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-12-11T09:20:13+00:00","article_modified_time":"2023-12-11T09:20:14+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Diatheris to spearhead a new era in Type 1 diabetes management","datePublished":"2023-12-11T09:20:13+00:00","dateModified":"2023-12-11T09:20:14+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/"},"wordCount":246,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png","keywords":["Education","Financing","Healthcare","Personalized Medicine","R&amp;D"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/","url":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/","name":"Diatheris to spearhead a new era in Type 1 diabetes management","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png","datePublished":"2023-12-11T09:20:13+00:00","dateModified":"2023-12-11T09:20:14+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Diatheris has made a promising leap in the field of diabetes treatment with a CHF 2.5 million grant from the Helmsley Charitable Trust.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/12\/Diatheris-1180x811-1.png","width":1180,"height":811,"caption":"This significant funding propels the Diatheris\u2019 efforts to revolutionize type 1 diabetes management through innovative treatment methodologies (from left to right: Pr. Roberto Coppari and Dr Giorgio Rimadori). | \u00a9 Diatheris"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/diatheris-to-spearhead-a-new-era-in-type-1-diabetes-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Diatheris to spearhead a new era in Type 1 diabetes management"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=21530"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21530\/revisions"}],"predecessor-version":[{"id":21535,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21530\/revisions\/21535"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/21531"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=21530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=21530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=21530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}